1Gerald BA, Jai R, Vivette DA. Secondary glomerular diseases: amyloidosis. In: Brenner BM, Rector FC. The Kidney. Vol Ⅱ. 6th ed.USA. W. B. Sannders Company. 2000:1386 - 1390.
2Sullivan TP, King LE, Boyd AS. Colchicine in dematology. J Am Acad Dematol, 1998, 39:993 - 999.
3Lange U, Schumann C, Schmidt KL. Current aspects of colchicines therapy: classical indication and new therapeutic uses. Eur J Med Res, 2001, 6:150 - 160.
4Dhodapkar MV, Jagannath S, Vesole D, et al. Treatment of AL-amyloidosis with dexamethasone plus alpha interferon. Leuk Lymphoma, 1997, 27 : 351 - 356.
5Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicines alone melphalan, prednisone, and colchicines versus colchicines only. N Engl J Med, 1997, 336:1202 -1207.
6Comenzo RL, Vosburgh E, Simms RW, et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis:one-year follow-up in five patients. Blood, 1996, 88 : 2801 - 2806.
7Wardley AH, Jayson GC, Goldsmith DJ, et al. The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine doxorubicin and dexamethasone. Br J Cancer, 1998, 78 : 774 -776.
8Merlini G, Ascari E, Amboldi N, et al. Interaction of the anthracycine 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci USA, 1995, 92:2959 - 2963.
9Merlini G, Anesi E, Garini P, et al. Treatment of AL amyloidosis with 4'-iodo-4'-deoxydoxorubicin: an update. Blood, 1999, 93:1112 - 1113.
10Menges M, Steffen HN. Secondary amyloidosis in ulcerative colitis-successful treatment with colchicines. Z Gastroenterol, 1996, 34 : 753 - 756.
10Comenzo RL, Vosburgh E, Simms RW, et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood,1996, 88: 2801-2806.
